Smart micro/nanoneedles for gene delivery

Document Type : Review Article

Authors

1 School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

2 Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

3 Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

4 Departments of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

5 Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

6 Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

10.22038/ijbms.2026.93562.20184

Abstract

Gene therapy, a transformative field in biomedicine, holds immense promise for treating a wide range of diseases. Smart micro/nanoneedles (MNs/NNs) emerged as non-viral carriers, offering safety and reduced immunogenicity, in addition to precise and controlled gene delivery, and represent promising platforms for gene delivery. They can also be tailored to respond to specific biological or environmental triggers, enabling precise targeting and localized delivery, ensuring that therapeutic genes reach their intended destination. Despite significant progress, challenges persist in scalable manufacturing, biocompatibility and safety, and genetic cargo stability. The incorporation of artificial intelligence (AI) into design and predictive modelling offers promising and cost-effective solutions to these limitations. This review provides a comprehensive analysis of MN/NN fabrication methodologies that enable structural and functional customization, while highlighting the interdisciplinary nature of MN/NN technologies and their transformative role in the future of gene therapy.

Graphical Abstract

Smart micro/nanoneedles for gene delivery

Keywords

Main Subjects


1. Qie B, Tuo J, Chen F, Ding H, Lyu L. Gene therapy for genetic diseases: Challenges and future directions. MedComm 2025; 6: e70091.
2. Henderson ML, Zieba JK, Li X, Campbell DB, Williams MR, Vogt DL, et al. Gene therapy for genetic syndromes: Understanding the current state to guide future care. BioTech 2024; 13: 1.
3. Shahgordi S, Oroojalian F, Hashemi E, Hashemi M. Recent advances in development of nano-carriers for immunogene therapy in various complex disorders. Iran J Basic Med Sci 2022;  25:134-147.
4. Abas MDM, Asri MFM, Yusafawi NAS, Rosman NAZ, Baharudin NAZ, Taher M, et al. Advancements of gene therapy in cancer treatment: A comprehensive review. Pathol Res Pract 2024; 261: 155509.
5. Belete TM. The current status of gene therapy for the treatment of cancer. Biologics 2021: 67-77.
6. Azimifar MA, Hashemi M, Babaei N, Salmasi Z, Doosti A. Interleukin gene delivery for cancer gene therapy: In vitro and in vivo studies. Iran J Basic Med Sci 2023; 26: 128-138
7. Wu Y, Zhang H. Treatment of infectious diseases by in vivo gene editing. Natl Sci Open 2023; 2: 20220061. 
8. Danaeifar M. Recent advances in gene therapy: Genetic bullets to the root of the problem. Clin Exp Med 2023; 23: 1107-1121.
9. Singh D, Singh S, Tandon N, Thakur A, Bedi N. Emerging trends in nanomedicine: The role of RNAi-based therapies and onpattro’s clinical journey. Iran J Basic Med Sci 2026; 29: 812-822. 
10. Zinder ND, Lederberg J. Genetic exchange in Salmonella. J Bacteriol 1952; 64: 679-699.
11. Temin HM. Mixed infection with two types of Rous sarcoma virus. Virol J  1961; 13: 158-163.
12. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, et al. T lymphocyte-directed gene therapy for ADA- SCID: Initial trial results after 4 years. Science 1995; 270: 475-480.
13. Wirth T PN, Ylä-Herttuala S. History of gene therapy. Gene 2013;525:162-169.
14. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737-747.
15. Alhasso B, Shareef A, Baldaniya L, Oweis R, Jyothi SR, Singh U, et al. CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeutics. Iran J Basic Med Sci 2025; 28: 1279-1300. 
16. Lotfi M, Morshedi Rad D, Mashhadi SS, Ashouri A, Mojarrad M, Mozaffari-Jovin S, et al. Recent advances in CRISPR/Cas9 delivery approaches for therapeutic gene editing of stem cells. Stem Cell Rev Rep 2023; 19: 2576-2596. 
17. Khademi Z, Ramezani M, Alibolandi M, Zirak MR, Salmasi Z, Abnous K, et al. A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411. Carbohydr Polym 2022; 292: 119691.
18. Miller JC, Holmes MC, Wang J, Guschin DY, Lee Y-L, Rupniewski I, et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 2007; 25: 778-785.
19. Chen X. Current and future technological advances in transdermal gene delivery. Adv Drug Deliv Rev 2018; 127: 85-105.  
20. Escoffre J-M, Teissié J, Rols M-P. Gene transfer: How can the
biological barriers be overcome? J Membr Biol 2010; 236: 61-74.
21. Sabatino DE, Bushman FD, Chandler RJ, Crystal RG, Davidson BL, Dolmetsch R, et al. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective. Mol Ther 2022; 30: 2646-2663.
22. Barquinero J, Eixarch H, Perez-Melgosa M. Retroviral vectors: New applications for an old tool. Gene Ther 2004; 11: S3-S9.
23. Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol 2007; 36: 184-204.
24. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther 1998; 80: 35-47. 
25. Yang Y, Su Q, Wilson JM. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol 1996; 70: 7209-7212.
26. Salmasi Z, Hashemi M, Mahdipour E, Nourani H, Abnous K, Ramezani M. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo. Biotechnol Prog 2020; 36: e3025. 
27. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 2006; 17: 253-263. 
28. Haigh O, Depelsenaire AC, Meliga SC, Yukiko SR, McMillan NA, Frazer IH, et al. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array. J Control Release 2014; 194: 148-156.
29. Salmasi Z, Mokhtarzadeh A, Hashemi M, Ebrahimian M, Farzad SA, Parhiz H, et al. Effective and safe in vivo gene delivery based on polyglutamic acid complexes with heterocyclic amine modified-polyethylenimine. Colloids Surf B Biointerfaces 2018; 172: 790-796.
30. Cole G, Ali AA, McCrudden CM, McBride JW, McCaffrey J, Robson T, et al. DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system. Eur J Pharm Biopharm 2018; 127: 288-297.
31. Ramamoorth M, Narvekar A. Non viral vectors in gene therapy-an overview. J Clin Diagn Res 2015; 9: GE01. 
32. Bråve A, Gudmundsdotter L, Sandström E, Haller BK, Hallengärd D, Maltais AK, et al. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine 2010; 28: 8203-8209.
33. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW. Electroporation-enhanced gene delivery in mammary tumors. Gene Ther 2000; 7: 541-547.
34. Stein U, Walther W, Stege A, Kaszubiak A, Fichtner I, Lage H. Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. Mol Ther 2008; 16: 178-186.
35. Lin MT, Wang F, Uitto J, Yoon K. Differential expression of tissue-specific promoters by gene gun. Br J Dermatol 2001; 144: 34-39.
36. Pamornpathomkul B, Wongkajornsilp A, Laiwattanapaisal W, Rojanarata T, Opanasopit P, Ngawhirunpat T. A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin. Int J Nanomed 2017; 12: 885-898.
37. Mehier-Humbert S, Guy RH. Physical methods for gene transfer: Improving the kinetics of gene delivery into cells. Adv. Drug Deliv. Rev. 2005; 57: 733-753.
38. Hu Y, Xu B, Xu J, Shou D, Liu E, Gao J, et al. Microneedle-assisted dendritic cell-targeted nanoparticles for transcutaneous DNA immunization. Polym Chem 2015; 6: 373-379.
39. Shin CI, Jeong SD, Rejinold NS, Kim Y-C. Microneedles for vaccine delivery: Challenges and future perspectives. Ther Deliv 2017; 8: 447-460.
40. Phoka T, Thanuthanakhun N, Visitchanakun P, Dueanphen N, Wanichwecharungruang N, Leelahavanichkul A, et al. Detachable-dissolvable-microneedle as a potent subunit vaccine delivery device that requires no cold-chain. Vaccine: X 2023; 15: 100398.
41. Saeedi M, Morteza-Semnani K, Akbari J, Hajheydari Z, Goodarzi A, Rostamkalaei SS, et al. Green formulation of spironolactone loaded chitosan-coated nano lipid carrier for treatment of acne vulgaris: A randomized double-blind clinical trial. Adv Pharm Bull 2023; 14: 161.
42. Chabri F, Bouris K, Jones T, Barrow D, Hann A, Allender C, et al. Microfabricated silicon microneedles for nonviral cutaneous gene delivery. Br J Dermatol 2004; 150: 869-877.
43. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1998; 87: 922-925.
44. Donnelly RF, Moffatt K, Alkilani AZ, Vicente-Pérez EM, Barry J, McCrudden MT, et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: A pilot study centred on pharmacist intervention and a patient information leaflet. Pharm Res 2014; 31: 1989-1999.
45. Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, Allen MG, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg 2001; 92: 502-504.
46. Ali AA, McCrudden CM, McCaffrey J, McBride JW, Cole G, Dunne NJ, et al. DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles. Nanomed Nanotechnol Biol Med 2017; 13: 921-932.
47. DeMuth PC, Min Y, Huang B, Kramer JA, Miller AD, Barouch DH, et al. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater 2013; 12: 367-376.
48. Duong HTT, Yin Y, Thambi T, Nguyen TL, Phan VG, Lee MS, et al. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy. Biomater 2018; 185: 13-24.
49. Liu B, Yi X, Zheng Y, Yuan Z, Yang J, Yang J, et al. A Review of Nano/Micro/Milli Needles Fabrications for Biomedical Engineering. Chin J Mech Eng 2022; 35: 106.
50. Akbuğa FJ, Arpa MD, Şalva E. Nanoneedle-Based Transdermal Gene Delivery: A Minimally Invasive Strategy for Gene Therapy. Int. J. Mol. Sci. 2025; 26: 6235.
51. Bagde A, Dev S, Sriram LMK, Spencer SD, Kalvala A, Nathani A, et al. Biphasic burst and sustained transdermal delivery in vivo using an AI-optimized 3D-printed MN patch. Int J Pharm 2023: 122647.
52. Duong HTT, Kim NW, Thambi T, Phan VG, Lee MS, Yin Y, et al. Microneedle arrays coated with charge reversal pH-sensitive copolymers improve antigen presenting cells-homing DNA vaccine delivery and immune responses. J Control Release 2018; 269: 225-234.
53. Xu Q, Li X, Zhang P, Wang Y. Rapidly dissolving microneedle patch for synergistic gene and photothermal therapy of subcutaneous tumor. J Mater Chem B 2020; 8: 4331-4339.
54. Yang HW, Ye L, Guo XD, Yang C, Compans RW, Prausnitz MR. Ebola vaccination using a DNA vaccine coated on PLGA‐PLL/γPGA nanoparticles administered using a microneedle patch. Adv Healthc Mater2017; 6: 1600750.
55. Kim M, Jung B, Park J-H. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomater 2012; 33: 668-678.
56. Xu C, Wu F, Duan Z, Rajbanshi B, Qi Y, Qin J, et al. Microneedle-aided nanotherapeutics delivery and nanosensor intervention in advanced tissue regeneration. J Nanobiotechnology 2025; 23: 330.
57. Liu G, Deng Y, Song Y, Sui Y, Cen J, Shao Z, et al. Transdermal delivery of adipocyte phospholipase A2 siRNA using microneedles to treat thyroid associated ophthalmopathy-related proptosis. Cell Transplant 2021; 30: 9636897211010633.
58. Deng Y, Chen J, Zhao Y, Yan X, Zhang L, Choy K, et al. Transdermal Delivery of siRNA through Microneedle Array. Sci Rep 2016; 6: 21422.
59. Chong RHE, Gonzalez-Gonzalez E, Lara MF, Speaker TJ, Contag CH, Kaspar RL, et al. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. J Control Release 2013; 166: 211-219.
60. Seong H, Higgins SG, Penders J, Armstrong JPK, Crowder SW, Moore AC, et al. Size-tunable nanoneedle arrays for influencing stem cell morphology, gene expression, and nuclear membrane curvature. ACS Nano 2020; 14: 5371-5381.
61. He G, Chen H-J, Liu D, Feng Y, Yang C, Hang T, et al. Fabrication of various structures of nanostraw arrays and their applications in gene delivery. Adv Mater Interfaces 2018; 5: 1701535.
62. Chiappini C, De Rosa E, Martinez JO, Liu X, Steele J, Stevens MM, et al. Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization. Nat Mater 2015; 14: 532-539.
63. Luo X, Yang L, Cui Y. Microneedles: Materials, fabrication, and biomedical applications. Biomed Microdevices 2023; 25: 20.
64. Saurer EM, Flessner RM, Sullivan SP, Prausnitz MR, Lynn DM. Layer-by-layer assembly of DNA-and protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules 2010; 11: 3136-3143.
65. Lutton REM, Larrañeta E, Kearney M-C, Boyd P, Woolfson AD, Donnelly RF. A novel scalable manufacturing process for the production of hydrogel-forming microneedle arrays. Int J Pharm 2015; 494: 417-429.
66. Han D, Morde R, Mariani S, La Mattina A, Vignali E, Yang C, et al. 4D printing of a bioinspired microneedle array with backward-facing barbs for enhanced tissue adhesion. Adv Funct Mater 2020; 30: 1909197.
67. Vander Straeten A, Sarmadi M, Daristotle JL, Kanelli M, Tostanoski LH, Collins J, et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat Biotechnol 2024; 42: 510-517.
68. Lee K, Kim JD, Lee CY, Her S, Jung H. A high-capacity, hybrid electro-microneedle for in-situ cutaneous gene transfer. Biomater 2011; 32: 7705-7710.
69. Li Y, Zhang H, Yang R, Laffitte Y, Schmill U, Hu W, et al. Fabrication of sharp silicon hollow microneedles by deep-reactive ion etching towards minimally invasive diagnostics. Microsyst Nanoeng 2019; 5: 41. 
70. Jung D, Rejinold NS, Kwak JE, Park SH, Kim YC. Nano-patterning of a stainless steel microneedle surface to improve the dip-coating efficiency of a DNA vaccine and its immune response. Colloids Surf B Biointerfaces 2017; 159: 54-61.
71. Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 2002; 8: 415-419.
72. Rezapour Sarabi M, Alseed MM, Karagoz AA, Tasoglu S. Machine learning-enabled prediction of 3D-printed microneedle features. Biosensors 2022; 12: 491.
73. Jin Q, Chen HJ, Li X, Huang X, Wu Q, He G, et al. Reduced graphene oxide nanohybrid-assembled microneedles as mini-invasive electrodes for real-time transdermal biosensing. Small 2019; 15: e1804298.
74. Pearton M, Saller V, Coulman SA, Gateley C, Anstey AV, Zarnitsyn V, et al. Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression. J Control Release 2012; 160: 561-569.
75. Kim Y-C, Song J-M, Lipatov AS, Choi S-O, Lee JW, Donis RO, et al. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. Eur J Pharm Biopharm 2012; 81: 239-247.
76. Raju L, Hiremath SS. A state-of-the-art review on micro electro-discharge machining. Procedia Technology 2016; 25: 1281-1288.
77. García-López E, Siller HR, Rodríguez CA. Study of the fabrication of AISI 316L microneedle arrays. Procedia Manuf 2018; 26: 117-124.
78. Azizi Machekposhti S, Khanna S, Shukla S, Narayan R. Microneedle fabrication methods and applications. MRS Commun 2023; 13: 212-224.
79. DeMuth PC, Su X, Samuel RE, Hammond PT, Irvine DJ. Nano‐layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA. Adv Mater 2010; 22: 4851-4856.
80. Li X, Xu Q, Wang J, Zhang P, Wang Y, Ji J. A gene-coated microneedle patch based on industrialized ultrasonic spraying technology with a polycation vector to improve antitumor efficacy. J Mater Chem B 2021; 9: 5528-5536.
81. Gonzalez-Gonzalez E, Speaker TJ, Hickerson RP, Spitler R, Flores MA, Leake D, et al. Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). Mol Ther 2010; 18: 1667-1674.
82. Biswas A, Bayer IS, Biris AS, Wang T, Dervishi E, Faupel F. Advances in top–down and bottom–up surface nanofabrication: Techniques, applications & future prospects. Adv Colloid Interface Sci 2012; 170: 2-27.
83. Golshadi M, Wright LK, Dickerson IM, Schrlau MG. High-Efficiency Gene Transfection of Cells through Carbon Nanotube Arrays. Small 2016; 12: 3014-3020.
84. Wang Y, Yang Y, Yan L, Kwok SY, Li W, Wang Z, et al. Poking cells for efficient vector-free intracellular delivery. Nat Commun 2014; 5: 4466.
85. Cole G, McCaffrey J, Ali AA, McBride JW, McCrudden CM, Vincente-Perez EM, et al. Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation. Hum Vaccin Immunother2017; 13: 50-62.
86. Koh KJ, Liu Y, Lim SH, Loh XJ, Kang L, Lim CY, et al. Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch). Sci Rep 2018; 8: 11842.
87. Noh I, Lee K, Rhee YS. Microneedle systems for delivering nucleic acid drugs. J Pharm Investig 2022; 52: 273-292.
88. Tang T, Deng Y, Chen J, Zhao Y, Yue R, Choy KW, et al. Local administration of siRNA through microneedle: optimization, bio-distribution, tumor suppression and toxicity. Sci Rep 2016; 6: 30430.
89. Li X, Xu Q, Zhang P, Zhao X, Wang Y. Cutaneous microenvironment responsive microneedle patch for rapid gene release to treat subdermal tumor.  J Control Release 2019; 314: 72-80.
90. Makvandi P, Jamaledin R, Chen G, Baghbantaraghdari Z, Zare EN, Di Natale C, et al. Stimuli-responsive transdermal microneedle patches. Mater Today (Kidlington) 2021; 47: 206-222.
91. Liu X, Song H, Sun T, Wang H. Responsive Microneedles as a New Platform for Precision Immunotherapy. Pharmaceutics 2023; 15:1407.
92. Karimi M, Ghasemi A, Zangabad PS, Rahighi R, Basri SMM, Mirshekari H, et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev 2016; 45: 1457-1501.
93. van den Berg JH, Oosterhuis K, Hennink WE, Storm G, van der Aa LJ, Engbersen JF, et al. Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. J Control Release 2010; 141: 234-240.
94. Pearton M, Allender C, Brain K, Anstey A, Gateley C, Wilke N, et al. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm Res 2008; 25: 407-416.
95. Yin Y, Su W, Zhang J, Huang W, Li X, Ma H, et al. Separable microneedle patch to protect and deliver DNA nanovaccines against COVID-19. ACS Nano 2021; 15: 14347-14359.
96.Wei Z, Zheng S, Wang R, Bu X, Ma H, Wu Y, et al. A flexible microneedle array as low-voltage electroporation electrodes for in vivo DNA and siRNA delivery. Lab on a Chip 2014; 14: 4093-4102.
97. Hisazumi J, Kobayashi N, Nishikawa M, Takakura Y. Significant role of liver sinusoidal endothelial cells in hepatic uptake and degradation of naked plasmid DNA after intravenous injection. Pharm Res 2004; 21: 1223-1228.
98. Wang M, Han Y, Yu X, Liang L, Chang H, Yeo DC, et al. Upconversion nanoparticle powered microneedle patches for transdermal delivery of siRNA. Adv Healthc Mater 2020; 9: 1900635.
99. Piotrowski-Daspit AS, Kauffman AC, Bracaglia LG, Saltzman WM. Polymeric vehicles for nucleic acid delivery. Adv Drug Deliv Rev 2020; 156: 119-132.
100.    Blömer U, Naldini L, Verma IM, Trono D, Gage FH. Applications of gene therapy to the CNS. Hum Mol Genet 1996; 5: 1397-1404.
101. Shi H, Xue T, Yang Y, Jiang C, Huang S, Yang Q, et al. Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease. Sci Adv 2020; 6: eaaz3621.
102.    Dinh L, Mahon L, Yan B. Nano-encapsulation and conjugation applied in the development of lipid nanoparticles delivering nucleic acid materials to enable gene therapies. Appl Nano 2024; 5: 143-161.
103. Liang X, Zhang J, Ou H, Chen J, Mitragotri S, Chen M. Skin delivery of siRNA using sponge spicules in combination with cationic flexible liposomes. Mol Ther Nucleic Acids 2020; 20: 639-648.
104. Pan J, Ruan W, Qin M, Long Y, Wan T, Yu K, et al. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles. Sci Rep 2018; 8: 1117.
105. Gong D, Ben-Akiva E, Singh A, Yamagata H, Est-Witte S, Shade JK, et al. Machine learning guided structure function predictions enable in silico nanoparticle screening for polymeric gene delivery. Acta Biomater 2022; 154: 349-358.
106. Kumar A, Wonganan P, Sandoval MA, Li X, Zhu S, Cui Z. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release 2012; 163: 230-239.
107. Ingrole RSJ, Gill HS. Microneedle coating methods: A review with a perspective. J Pharmacol Exp Ther 2019; 370: 555-569.
108. Briffault E, Garcia-Garcia P, Martinez-Borrajo R, Evora C, Delgado A, Diaz-Rodriguez P. Harnessing extracellular vesicle membrane for gene therapy: EVs-biomimetic nanoparticles. Colloids Surf B Biointerfaces 2024; 239: 113951.
109. Chen W, Li H, Shi D, Liu Z, Yuan W. Microneedles as a delivery system for gene therapy. Front Pharmacol 2016; 7: 137.
110. Zhang X, Zhou C, Chen T, Jiang Z, Lu C, Wu C, et al. State-of-the-art strategies to enhance the mechanical properties of microneedles. Int J Pharm 2024; 663: 124547.
111. Makvandi P, Kirkby M, Hutton AR, Shabani M, Yiu CK, Baghbantaraghdari Z, et al. Engineering microneedle patches for improved penetration: Analysis, skin models and factors affecting needle insertion. Nanomicro Lett 2021; 13: 93.
112. Sun Y, Miao D, Zeng Z, Li X, Pu Y, Liu L, et al. Recent advances in micro/nanoneedle arrays mediated intracellular delivery of biomacromolecules in vitro and in vivo. Adv Funct Mater 2025: 2422234.
113. Han S, Wan H, Lin D, Guo S, Dong H, Zhang J, et al. Contribution of hydrophobic/hydrophilic modification on cationic chains of poly (ε-caprolactone)-graft-poly (dimethylamino ethylmethacrylate) amphiphilic co-polymer in gene delivery. Acta Biomater 2014; 10: 670-679.
114. He W, Kong S, Lin R, Xie Y, Zheng S, Yin Z, et al. Machine learning assists in the design and application of microneedles. Biomimetics 2024; 9: 469.
115. Chumpu R, Chu C-L, Treeratanaphitak T, Marukatat S, Hsu S-H. Physics-informed graph neural networks accelerating microneedle simulations towards novelty of micro-nano scale materials discovery. Eng Appl Artif Intell 2023; 126: 106894.
116. Chiappini C, Campagnolo P, Almeida CS, Abbassi-Ghadi N, Chow LW, Hanna GB, et al. Mapping local cytosolic enzymatic activity in human esophageal mucosa with porous silicon nanoneedles. Adv Mater 2015; 27: 5147-5152.
117. Sun Z, Hou Y. Intelligent micro/nanorobots for improved tumor therapy. BMEMat 2023; 1: e12012.
118. Shah SA, Oakes RS, Kapnick SM, Jewell CM. Mapping the mechanical and immunological profiles of polymeric microneedles to enable vaccine and immunotherapy applications. Front Immunol 2022; 13: 843355.
119. Zhang XP, He YT, Li WX, Chen BZ, Zhang CY, Cui Y, et al. An update on biomaterials as microneedle matrixes for biomedical applications. J Mater Chem B 2022; 10: 6059-6077.
120. Choi H-J, Yoo D-G, Bondy BJ, Quan F-S, Compans RW, Kang S-M, et al. Stability of influenza vaccine coated onto microneedles. Biomaterials 2012; 33: 3756-3769.
121. McCaffrey J, McCrudden CM, Ali AA, Massey AS, McBride JW, McCrudden MT, et al. Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device. J Control Release 2016; 226: 238-247.
122. Cary JH, Li BS, Maibach HI. Dermatotoxicology of microneedles (MNs) in man. Biomed Microdevices 2019; 21: 66.
123. Tarbox TN, Watts AB, Cui Z, Williams III RO. An update on coating/manufacturing techniques of microneedles. Drug Deliv Transl Res 2018; 8: 1828-1843.
124. Moawad F, Pouliot R, Brambilla D. Dissolving microneedles in transdermal drug delivery: A critical analysis of limitations and translation challenges. J Control Release 2025; 383: 113794.